bpc-157 human clinical trials evidence review safety This doesn't mean is side-effect-free. But it does add to the signal. Credit to @dr.kseniamiami for mentioning this study on our recent podcast recording last week which will be out If BPC-157 worked as well
Description
Project Administration: JKH
Swab the rubber stoppers of both the tirzepatide vial and the bacteriostatic water vial with alcohol
The concentration is the variable that changes everything
2020;10(1):p
A common protocol, for example, is to begin with about 20 mg of NAD+ (corresponding to a small volume from the vial, typically around 0.1 mL depending on concentration) administered subcutaneously and gradually increase the dose over subsequent injections up to around 100 mg per injection
Injectable BPC-157 may be preferred when higher systemic availability or musculoskeletal support is the goal
